期刊名称：MOVEMENT DISORDERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Movement Disorders publishes Reviews, Viewpoints, Full Length Articles, Historical Reports, Brief Reports, Clinical/Scientific Notes, Videotape Briefs, Patient/Imaging Briefs, and Letters.
|
Original manuscripts, i.e., those that have not been published elsewhere except in abstract form, on the diagnosis, therapeutics, pharmacology, biochemistry, physiology, etiology, genetics, and epidemiology of movement disorders, will be considered for publication. Appropriate subjects include the etiology, diagnosis, management, and basic science of parkinsonism, chorea, tremors, dystonia, myoclonus, tics, tardive dyskinesia, spasticity, and ataxia.
|
| To view the Technical Note by Drs. Jog and Grantier on methods for digital video recording, storage, and communication of movement disorders, click here. This article is available to all readers.
Abstracting and Indexing Information
- Abstracts in Anthropology (Baywood Publishing)
- Current Advances in Neuroscience (Elsevier)
- Current Awareness in Biological Sciences (Elsevier)
- Current Contents®/Clinical Medicine (Thomson ISI)
- Current Contents®/Life Sciences (Thomson ISI)
- EMBASE/Excerpta Medica (Elsevier)
- Index Medicus/MEDLINE/PubMed (NLM)
- Journal Citation Reports/Science Edition (Thomson ISI)
- MEDLINE/PubMed (NLM)
- Neuroscience Citation Index™ (Thomson ISI)
- RECAL Legacy Database ()
- Reference Update (Thomson ISI)
- RILM Abstracts of Music Literature (RILM)
- Science Citation Index Expanded™ (Thomson ISI)
- Science Citation Index® (Thomson ISI)
- SCOPUS (Elsevier)
- Web of Science® (Thomson ISI)
Instructions to Authors
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
Author Guidelines
MANUSCRIPT SUBMISSION INFORMATION
Movement Disorders is pleased to offer authors web-based manuscript submission and peer-review.
Authors are required to submit online at http://mc.manuscriptcentral.com/mds. All accompanying supplementary material (e.g., videos, appendices) should also be submitted online.
Editorial Office Information
Jose A. Obeso, MD, PhD
University of Navarra
Pamplona, Spain
Phone: 34-948-194700, ext. 2038
E-mail: movementdisorders.east@gmail.com
C. Warren Olanow, MD, FRCPC
Mount Sinai School of Medicine
New York, New York, USA
Phone: 1-212-241-8435
E-mail: cwolanow@gmail.com
Submit your manuscripts online at http://mc.manuscriptcentral.com/mds. Please note: This journal does not accept Microsoft WORD 2007 documents at this time. Please use WORD’s “Save As” option to save your document as an older (.doc) file type. Manuscripts submitted online are received on the day of submission and quickly assigned to reviewers. Through your individual Author Center on this website, you can view the status of your manuscript as it progresses through the review process. Notification of the final disposition of each manuscript will be sent by E-mail to the corresponding author on the day of decision. To submit your manuscript online:
- Go to the submission website
- Click on the "Check for Existing Account" button at the bottom of the opening page. If you do not already have an account, then create one by clicking on the "Create an Account" button. You will then be able to submit your manuscript.
- Click on “Author Center.” Follow the on-screen instructions carefully. Tables and figures should be uploaded as individual files and not part of the manuscript text. (You do not need to mail hard copies of your manuscript).
- At the end of a successful submission, you will see a confirmation screen with your manuscript number, and you will receive a separate E-mail confirmation of manuscript reception by the journal. If these two messages do not appear, then go into your Author Center and make sure that you have clicked on the “Submit” button or contact technical support at http://mchelp.manuscriptcentral.com/gethelpnow/question.htm.
Video Submission
General Information: When submitting manuscripts online, authors will be able to indicate whether the article has accompanying video. Video must be submitted with manuscripts online in a digital format. If an article includes video, the upper right corner of the title page of the manuscript must be marked “Video is part of ms.” All video clips must be limited to 90 seconds unless specific approval is obtained from the editorial office. Authors must also supply, as part of the manuscript, a video legend for the full video clip. If the author does not have the capacity to generate an electronic video, the author may contact the editorial office for assistance.
Content: Video content must be brief; less than 90 seconds total, except for very special instances, which must be cleared beforehand with the appropriate editor.Legends for the video segments should be placed at the end of the article.The video should be high quality (both in content and visibility). The video should be edited to ensure maximal efficiency and make a specific point; particularly, it should demonstrate the features described in the text of the manuscript. In addition, the content of the video sequence should directly follow the content of the video legend.
Production: The use of text and/or special transition effects between the titles, subtitles and video segments is NOT recommended as these will be edited out for final DVD production and portions of your video may be lost.
Patient Consent: The corresponding author must confirm in the author copyright form (Article V) that he or she has received a signed release form from each patient videotaped authorizing the offline and/or online distribution of this video material. Videos will not be sent out for review until the signed copyright form (Article V) with this documentation is received.
Review: The editorial office will hold the article until the video media arrives and will then send both the article and the video for review.The date of submission will be the date all components of the article arrive at the editorial office.
The Editors reserve the right to request additional video editing by the authors (which may delay publication) and to edit video submissions prior to posting and/or distribution, including the insertion of a voiceover by the Editor.
For tips on preparing your video for submission, see the Technical Note by Jog and Grantier on digital video preparation. This article appears in volume 16, issue 6, and is available to all readers.
Cover Letter, Author Copyright Form, and Legal Information
Cover Letter. The cover letter must confirm that all authors have read the manuscript, the paper has not been previously published, and is not under simultaneous consideration by another journal. Also, a statement that no ghost writing by anyone not named on the author list (see Editorial in Movement Disorders 2005;20:1536) must be included. Identify the corresponding author and provide a complete mailing address, telephone and fax numbers, and email address.
Author Copyright Form. The author Copyright form includes (1) a statement on authorship responsibility, (2) a statement on financial disclosure, (3) one of two statements on copyright or federal employment, and (4) a statement of acknowledgment. Each of the first three statements must be read and signed by each co-author. The corresponding author must sign the acknowledgment statement (See the copyright form at the top of this page). A fifth requirement may apply: When there is accompanying video or photographs on which patients can be identified, the corresponding author must sign the video consent section (Article V).
Group Authorship. If authorship is attributed to a group (either solely or in addition to one or more individual authors), all members of the group must meet the full criteria and requirements for authorship. A group must designate one or more individuals as authors or members of a writing group who meet full authorship criteria and requirements and who will take responsibility for the group, in which case the other group members are not authors but may be listed in an acknowledgment (Flanagin A, Fontanarosa PB, DeAngelis CD. Authorship for research groups. JAMA 2002;288:3166-3168).
Documentation of Author Roles. At the end of the manuscript, all authors must be listed, along with their specific roles in the project and manuscript preparation. These should include but not be restricted to:
1. Research project: A. Conception, B. Organization, C. Execution;
2. Statistical Analysis: A. Design, B. Execution, C. Review and Critique;
3. Manuscript: A. Writing of the first draft, B. Review and Critique;
Example:
AUTHOR ROLES: 1. Research project: A. Conception, B. Organization, C. Execution;
2. Statistical Analysis: A. Design, B. Execution, C. Review and Critique;
3. Manuscript: A. Writing of the first draft, B. Review and Critique;
e.g., Olanow: 1A, 1B, 2, 3A, 3B. Obeso: 1A, 1B, 1C, 2A, 3B.
The Editors will pre-screen submitted manuscripts. In the event that they do not find that the author is concordant with the listed effort, they will ask authors to revise the author’s roles before sending the manuscript out for peer review. The editors will also triage articles and reject without review submissions that are determined to have a low priority for publication.
Data Access and Responsibility. For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that (1) they have had full access to the data, (2) they have the right to publish all the data, and (3) they have had the right to obtain independent statistical analyses of the data. For any report containing original data, at least one author should indicate that he or she “takes responsibility for the integrity of the data and the accuracy of the data analysis” (DeAngelis CD, Fontanarosa PB, Flanagan A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001;286:89-91).
Patient Consent. When submitting a patient video or photograph in which a patient can be identified, the corresponding author must provide the Movement Disorders journal with a written confirmation (author copyright form, Article V) that stipulates that authorization signed by the patient has been obtained in compliance with any laws regarding patient authorizations relating to the use or disclosure of protected health information of the jurisdiction(s) to which the patient and the physician are subject including, if applicable, the United States Health Insurance Portability and Accountability Act of 1996 (“HIPAA”).1 Manuscripts including, without limitation, a patient video or photograph will not be reviewed until a signed author's accompanying statement (see Item V) has been received.
Copyright. The Movement Disorder Society will hold copyright on all published articles and videos.
The copyright transfer agreement form can be downloaded from the top of this page. If you are a government employee, please check the “Government-Owned Work” checkbox.
Financial Disclosures. All submissions require two entries that cover financial disclosure of all authors:
§ Financial disclosure related to research covered in this article: A statement that documents all funding sources and potential conflicts of interest from each author that relate to the research covered in the article submitted must be included on the title page, regardless of date. This material will be available online and may be printed at the discretion of the editors.
§ Full financial disclosure for the previous 12 months: A statement that documents all funding sources, regardless of relationship to the current research in the article, from each author must be attached to the article at the end of the manuscript on the last page. This material will be printed or posted on the journal website at the Editors’ discretion.
The copyright form that is signed by each author confirms that both of these entries are documented in the submitted material.
Expedited Publications
Online submission and peer review expedite the regular review process; however, Movement Disorders will attempt to accommodate authors of manuscripts dealing with extremely topical issues or with findings of critical scientific importance by offering Expedited Review and Publication. Authors wishing expedited review should indicate this need when submitting online. Once accepted, the entire text of an Expedited Publication will be placed on the Movement Disorders journal web page until it appears in the print version of the journal.
Scope
Movement Disorders publishes Full-length Articles, Reviews, Viewpoints, Brief Reports, and Letters. Case reports in which interesting diagnostic difficulties arose in which a definitive pathological or genetic diagnosis was ultimately made can be submitted for the Clinico-Pathological Grand Round section of the journal. The case history and the pathological findings should be submitted to the editors. If the editor determines that the report is appropriate for the Grand Round format two referees can be solicited to discuss the case and become co-authors of the report. All articles in Movement Disorders, including letters, can be accompanied by a video when appropriate.
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at www.blackwellpublishing.com/bauthor/english_language.asp. Japanese authors can also find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
- Full-Length Articles: Full-length articles present new data in any field related to movement disorders. Suggested length: Abstract up to 250 words, text up to 2700 words, and up to 5 tables and/or figures, legends. The word count must appear on the title page.
- Reviews and Viewpoints: Clinical and basic science Reviews or Viewpoints that provide a position statement or summary are generally published upon request or after agreement with the editors of Movement Disorders. Authors interested in writing Reviews or Viewpoints may contact the respective Editor-in-Chief, and unsolicited Reviews and Viewpoints will also be considered for publication. Suggested length will be individually discussed.
- Brief Reports: Brief reports are short reports, original studies, or evaluations.Suggested length: Abstract up to 150 words, text up to 1500 words, and up to 2 tables, and/or figures, legends. The word count must appear on the title page. This section may also include video-based reports of interesting cases or educational observations with a very brief clinical description. In addition, patient photographs or samples of imaging studies demonstrating a unique observation or educational point accompanied by a very brief commentary legend can be submitted.
- Letters: Letters to the Editor allow publication related to previously published material in the Journal or interesting new observations. This section is also the appropriate venue for brief reports or case histories with or without videos. A letter related to published materials may be submitted up to 12 weeks after the paper to which it refers was published in print. Text length can be up to 500 words with up to 5 references for letters related to published articles, up to 250 words and up to 5 references for letters related to published letters, and up to 700 words with up to 7 references for new cases. Letters may have up to 1 table and/or figure with legends. No abstract is needed but a title page is required.
- Clinical Trial Reports: Clinical Trial Reports must be written in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement (Moher D et al., JAMA 2001;285:1987–1991; see also Moher D et al., Lancet 2001;357:1191–1194). Authors should ensure that information on all of the critical design features listed in the CONSORT checklist is reported in the manuscript. (Reviewers are provided with the checklist to assess the manuscript for the relevant content). The CONSORT flow diagram (figure) should be included with the manuscript, clearly outlining the flow of patients through the trial. In addition, a statement is required in the cover letter specifically confirming that there has been no ghost writing by anyone not named on the author list (see Editorial in Movement Disorders 2005;20:1536). The precise financial relationship between a clinical trial sponsor and the authors must be delineated in the manuscript.
Form of Manuscripts.
The text of the manuscript should be in the following sequence: (1) Title page, (2) Abstract, (3) Introduction, (4) Methods, (5) Results, (6) Discussion, (7) Acknowledgment, (8) Authors' Roles, (9) Financial Disclosures of all authors (for the preceding 12 months), (10) References, (11) Video Legend, (12) Figures, and (13) Tables. Pages should be numbered in succession, the title page being one.
Title: Titles should be short, specific, and clear. They should not exceed 100 characters. Do not use abbreviations in the title.
Title Page:The opening page of each manuscript should include only: (1) article title; (2) authors' names and affiliations (indicate the specific affiliation of each author by superscript, Arabic numerals); (3) name, address, and telephone and fax numbers of the person to whom proofs should be addressed; (4) word count; (5) any necessary footnotes to these items; (6) a running title not exceeding 45 letters and spaces; (7) Key words; (8) Financial Disclosure/Conflict of Interest concerning the research related to the manuscript: All information on support and financial issues from all authors relative to the research covered in the submitted manuscript must be disclosed regardless of date. Other financial information unrelated to the current research covering the past year will be documented at the end of the manuscript (see below). Note that submissions without this Financial Disclosure on the Title Page will be returned to the author. For clinical trials, a statement on ghost-writing is required (Movement Disorders 2005;20:1536).
Abstract:The page following the title page of Full-Length Articles should include a brief abstract of up to 250 words describing the background, methods, results, and conclusions of the study. We encourage authors to submit papers with structured abstracts, especially for clinical trial papers. The page following the title page of a Brief Report should include a brief abstract of up to 100 words.
Key words: Up to six key words or terms should be provided following the abstract.
Introduction: Give a brief description of the background of the scientific contribution.
Methods:Informed consent: For experimental investigation of human or animal subjects, please state in this section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees, the principles outlined in the “Declaration of Helsinki” should be followed. For investigations in human subjects, state in this section the manner in which informed consent was obtained from the subjects. A letter of consent must accompany all photographs, patient descriptions, and pedigrees in which a possibility of identification exists. The authors are responsible for proper anonymisation of their patients.
Results: No specific regulations.
Discussion: No specific regulations.
Acknowledgment: No specific regulations.
Author Roles: List all authors along with their specific roles in the project and preparation of the manuscript. These may include but are not restricted to: 1) Research project: A. Conception, B. Organization, C. Execution; 2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; 3) Manuscript: A. Writing of the first draft, B. Review and Critique.
Full Financial Disclosures of all Authors for the Past Year: Information concerning all sources of financial support and funding for the preceding twelve months, regardless of relationship to current manuscript must be submitted with the following categories suggested. List sources or “none”.
|
Stock Ownership in medically-related fields |
Intellectual Property Rights |
|
Consultancies |
Expert Testimony |
|
Advisory Boards |
Employment |
|
Partnerships |
Contracts |
|
Honoraria |
Royalties |
|
Grants |
Other |
References: See “Details of Style” for the proper formatting of citations and References.
Video Legend: No specific regulations.
Tables and Figure Legends: Double-space legends of fewer than 40 words for tables and figures. For photomicrographs, include the type of specimen, original magnification, and stain type. Include internal scale-markers on photomicrographs. Where applicable, indicate the method used to digitally enhance images.
Tables: Tables should be typed neatly, each on a separate page, with a title above and any notes below. Explain all abbreviations. Do not repeat the same information in tables and figures or tables and text.
Figures and Illustrations: Adapt any figures to an appropriate size of art and letters to make them readable in the printed version. Illustrations in full color are accepted at additional charge from the publisher. Any illustration or figure from another publication must be acknowledged in the figure legend, and the copyright holder’s written permission to reprint in print and online edition of Movement Disorders must be submitted to the editors.
Copyright and Disclosure Forms The corresponding author should upload one PDF file that includes copyright and disclosure forms for all authors to the Movement Disorders submission site with the revised version of the paper. These forms also can be emailed to mdjedoffice@movementdisorders.org.
Digital Artwork Preparation
For best reproduction, electronic artwork files must be in TIFF or EPS format, at a resolution of 600 dpi or higher, sized to print. Movement Disorders offers Rapid Inspector™ to help ensure that your electronic graphics files are suitable for print purposes. This free, stand-alone software application will help you to inspect and verify illustrations right on your computer. Go to http://rapidinspector.cadmus.com/wi/index.jsp and create a new account.
Details of Style
No patient identifiers (e.g., patient initials) are to be included in the manuscript or video (e.g., case reports, tables, figures, etc.).
Units of measure: Conventional units of measure according to the Systeme International (SI) are preferred. The metric system is preferred for length, area, mass, and volume. Express temperature in degrees Celsius.
Drug Names: Use generic names only in referring to drugs, followed in parentheses after first mention by any commonly used generic variant.
Abbreviations: Follow the list of abbreviations given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (see section on References). For additional abbreviations, consult the CBE Style Manual (available from the Council of Biology Editors, 9650 Rockville Pike, Bethesda, Maryland 20814, USA) or other standard sources.
Spelling: American spelling is used throughout the Journal.
References
Movement Disorders complies with the reference style given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals". (See Annals of Internal Medicine 1982;96:766-771, or British Medical Journal 1982:284:1766-1770.)
References are to be cited in the text by number, and in the list of References they are to be numbered in the order in which they are cited. The reference section should be double-spaced at the end of the text, following the sample formats given below. Provide all authors' names when fewer than seven; when seven or more, list the first three and add et al. Provide article titles and inclusive pages. Accuracy of reference data is the responsibility of the author. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus (available from the Superintendent of Documents, U.S. Government Printing Office, Washington DC 20402, USA, DHEW Publication No. (NIH) 83-267; ISSN 0093-3821).
Sample References
· Journal article:
1. Horgan JH, O'Callaghan WG, Teo KK. Therapy of angina pectoris with low-dose perhexiline. J Cardiovasc Pharmacol 1981;3:566–572.
· Book:
2. Vanhoutte PM, Leusen I, editors. Vasodilatation. New York: Raven Press; 1981. 96 p.
· Chapter in a book:
3. Patrono C, Ciabattoni G, Pugliese F, et al. Effect of dietary variation in linoleic acid content on platelet aggregation and the major urinary metabolites of the E prostaglandins and (PGE-M) in infants. In: Hegyeli RJ, editor. Prostaglandins and cardiovascular disease. New York: Raven Press; 1981. p 111–122. (Atherosclerosis reviews; vol. 8).
Wiley's Journal Styles Are in EndNote.
Many authors use commercial software, such as EndNote, to organize references within their manuscripts. Using EndNote’s bibliographic management tools, authors can search bibliographic databases, build and organize reference collections, and then quickly arrange a bibliography in any Wiley journal style.
Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for Movement Disorders online at www.interscience.wiley.com/jendnotes/#m.
How to Order : To learn more about EndNote, or to purchase your own copy, go to http://interscience.wiley.com/jpages/bonus/end_note_promo.html.
Technical Support : If you need assistance using EndNote, contact endnote@isiresearchsoft.com, or visit http://www.endnote.com/support
Accepted Articles: Materials Required for Publication
After acceptance, please check to be sure that you have submitted your signed copyright transfer and author consent form as well as permissions forms (if applicable). Authors using images of their patients, whether in artwork or video format, must submit a copy (signed by the corresponding author) of the copyright transfer and author consent form. A sample form is available to authors on Manuscript Central.
Proofs
Proofs must be returned within 3 days of receipt; late return may cause a delay in publication of an article. Please check text, tables, legends, and references carefully. To expedite publication, page proofs rather than galleys will be sent electronically to the author, and it may be necessary to charge for alterations other than correction of printing errors.
E-mail proof pages to: Katie Balaski, Movement Disorders, John Wiley & Sons, Inc., Wiley-Blackwell, 111 River St., Mail Stop 8-02, Hoboken, NJ 07030-5774, USA. E-mail: kcelentano@wiley.com.
For Video Clips or Pictures of Patients (U.S. Contributors Only): The United States Health Insurance Portability and Accountability Act of 1996 (“HIPAA”)
According to HIPAA, the following core elements must be included in the consent form:
· 1. A specific and meaningful description of the information to be used
· 2. The name of the Physician and/or Hospital allowed to disclose the information
· 3. That the video clip and/or photograph will be submitted for publication in a peer-reviewed medical journal
· 4. That the video clip and/or photograph will eventually be used by the readers of a peer-reviewed medical journal for educational purposes
· 5. An expiration date that relates to the individual or the purpose of the use or disclosure
· 6. The individual’s signature and the date the authorization is signed.
In addition, the patient’s consent form should include the following:
· 1. A statement that the Patient has the right to revoke his or her consent in writing
· 2. A statement regarding whether the Physician has the ability to condition medical treatment on the Patient’s giving such consent
· 3. A statement that information, once disclosed, may be subject to further disclosure by the recipient journal, in which case confidentiality would no longer be assured. The consenting party must understand, additionally, that in some cases the video might be re-presented elsewhere because the journal has policies that allow permissions and/or use copyrighted materials with other educational organizations. The consenting party must understand that in such a case the signed author’s consent form may be shared with this third party and the consenting party consents to this sharing of information for educational purposes.
Editorial Board
EDITORS-IN-CHIEF
Jose A. Obeso, MD, PhD
University of Navarra
Pamplona, Spain
C. Warren Olanow, MD, FRCPC
Mount Sinai School of Medicine
New York, New York, USA
ASSOCIATE EDITORS
Erwan Bézard
Bordeaux, France
Karl D. Kieburtz
Rochester, New York, USA
Kailash P. Bhatia
London, United Kingdom
Serge Przedborski
New York, New York, USA
David J. Burn
Newcastle, United Kingdom
Kapil D. Sethi
Augusta, Georgia, USA
Assistant Editor
Manuel Alegre
Pamplona, Spain
CME Editor
Kelly Lyons
Kansas City, Kansas, USA
Assistant Editor
Michele Tagliati
New York, New York, USA
INTERNATIONAL EDITORIAL BOARD
Dag Aarsland
Stavanger, Norway
Angelo Antonini
Milan, Italy
Maren E. Bodden
Rotterdam, The Netherlands
Vincenzo Bonifati
Rotterdam, The Netherlands
Paolo Calabresi
Perugia, Italy
Richard Camicioli
Edmonton, Alberta, Canada
Mark R. Cookson
Bethesda, Maryland, USA
Ted Dawson
Balyimore, Maryland, USA
Nico Diederich
Noerdange, Luxembourg
Alfonso Fasano
Rome, Italy
Victor Fung
Westmead, Australia
Glenda Halliday
Sydney, Australia
Regina Katzenschlager
Vienna, Austria
Christina Klein
Luebeck, Germany
Paul Krack
Grenoble, France
Andres M. Lozano
Toronto, Ontario, Canada
Pablo Martinez-Martin
Madrid, Spain
Hiroshi Matsuda
Saitama, Japan
Mike McDermott
Rochester, New York, USA
Giuseppe Meco
Rome, Italy
Janis Miyasaki
Toronto, Ontario, Canada
Tetsutaro Ozawa
Niigata, Japan
Walter Paulus
Göttingen, Germany
Stephen G. Reich
Baltimore, Maryland, USA
EDITORIAL OFFICE
Julie Nash
Managing Editor, Movement Disorders
320 North Salem Street, Suite 205
Apex, NC 27502
Phone: 1-919-423-7009
E-mail: julie@jjeditorial.com
| 
